Depocyt® With Sorafenib in Neoplastic Meningitis
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Neoplastic Meningitis
Interventions: DRUG: DepoCyt|DRUG: Sorafenib
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Bayer